Phorbol myristate acetate-induced lung injury: involvement of reactive oxygen species

M Okuda1, H C Lee, B Chance

  • 1Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia.

Insights

Phorbol myristate acetate (PMA) causes lung injury dependent on its concentration, mediated by reactive oxygen species (ROS). Superoxide dismutase effectively blocked PMA-induced lung damage, indicating ROS are key drivers of this injury.

Area of Science:

  • Pulmonary Medicine
  • Biochemistry
  • Toxicology

Background:

  • Phorbol myristate acetate (PMA) is known to induce inflammation.
  • Reactive oxygen species (ROS) are implicated in various inflammatory processes.
  • The specific role of ROS in PMA-induced lung injury requires further elucidation.

Purpose of the Study:

  • To investigate whether reactive oxygen species (ROS) mediate phorbol myristate acetate (PMA)-induced lung injury in isolated rat lungs.
  • To determine the concentration-dependent effects of PMA on lung injury markers.

Main Methods:

  • Isolated rat lungs were perfused with a physiological salt-Ficoll solution.
  • Lucigenin-enhanced chemiluminescence was used to measure ROS production.
  • PMA was administered at different concentrations (0.03 and 0.15 micrograms ml-1).
  • The effects of ROS scavengers (superoxide dismutase, catalase, dimethylthiourea) and indomethacin were assessed.

Main Results:

  • PMA induced lung oedema, increased pulmonary arterial perfusion pressure (Ppa), and elevated ROS levels in a concentration-dependent manner.
  • Superoxide dismutase significantly inhibited PMA-induced increases in ROS, Ppa, and lung oedema.
  • Catalase, dimethylthiourea, and indomethacin partially attenuated lung oedema but did not fully inhibit ROS and Ppa increases.

Conclusions:

  • PMA-induced lung injury is concentration-dependent and critically mediated by ROS.
  • Superoxide radicals appear to be a primary contributor to PMA-induced lung injury.
  • Thromboxane plays a minor role in this model of lung injury.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Cellular Injury I: Introduction01:00

Cellular Injury I: Introduction

Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.